Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation is one of the more common side effects of Mounjaro (tirzepatide), affecting a meaningful proportion of people during treatment — particularly in the first few weeks or after a dose increase. The slowdown happens because tirzepatide delays gastric emptying, which gives your gut less to push through and reduces the frequency of bowel movements. Before reaching for a remedy, it helps to understand which options are safe to use alongside Mounjaro, which to avoid, and when a symptom needs medical attention rather than a pharmacist's shelf. These are prescription-only medicines, and what you need to know about Mounjaro includes how to manage common side effects safely, ideally with input from your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most prescribers start with the basics, and that is the right call. Increasing your fluid intake is the single most straightforward step, Mounjaro suppresses appetite, which often means people eat and drink less without realising it, and mild dehydration alone can be enough to stall the bowel. Aim for at least 1.5–2 litres of water across the day, particularly in the morning. Soluble fibre helps too: oats, flaxseed, cooked vegetables and fruit with the skin on all add bulk gently without the bloating that some high-fibre powders can cause when introduced too quickly.
If lifestyle adjustments aren't moving things along after a few days, an osmotic laxative such as macrogol (Movicol, Laxido) is generally considered appropriate alongside GLP-1 treatment. Osmotic laxatives draw water into the bowel rather than stimulating it directly, which tends to sit better alongside Mounjaro's gastric-slowing effect. Lactulose is another option widely used in the UK, though some people find it causes bloating. Bulk-forming laxatives like ispaghula husk (Fybogel) can also help, but they require adequate fluid intake to work safely, something to bear in mind given the appetite suppression. You can read more about the full picture of Mounjaro and constipation, including how commonly it occurs and why.
Always check any new medicine with your prescriber or pharmacist if you are unsure. Mounjaro slows gastric emptying, which can affect how quickly other oral medicines are absorbed, a practical reason to discuss any new treatment, even an over-the-counter one, before starting it.
Stimulant laxatives (bisacodyl tablets and senna are the most common examples) work by triggering bowel muscle contractions. They are not automatically off limits, and short-term use is unlikely to cause harm, but they can cause significant cramping if your gut is already sensitive from tirzepatide's effects on motility. Many people find the cramping more uncomfortable than the constipation itself, particularly in the early weeks of treatment. Starting with an osmotic laxative is usually the gentler route in.
Codeine-based painkillers are worth a specific mention because some people reach for them for other reasons while on Mounjaro. Opioids slow bowel transit considerably, meaning any constipation you are already experiencing is likely to worsen. If you need pain relief, discuss alternatives with your prescriber.
It is also worth being cautious with certain magnesium-based supplements marketed as 'gentle' constipation remedies online. At the wrong dose they can cause diarrhoea rather than relieving constipation, an overcorrection that is genuinely unpleasant and can lead to dehydration. For a broader look at how to address and prevent the problem day-to-day, practical steps for avoiding constipation on Mounjaro cover routine and dietary habits worth building from the start of treatment.
The NHS medicines page for tirzepatide lists the recognised side effects of Mounjaro and gives guidance on when to seek advice from a pharmacist or GP.
This is the part that matters most. Constipation itself is uncomfortable but rarely dangerous. The concern is that it can occasionally be hard to distinguish from something more serious, particularly pancreatitis, a known, though infrequent, side effect of GLP-1 medicines that the MHRA highlighted in a Drug Safety Update in January 2026.
Get urgent help (call 111 or go to A&E) if you experience severe stomach pain that does not ease, especially if it radiates to your back, comes with vomiting, or is significantly worse than anything you have felt before on this treatment. That pattern is not typical constipation and should not be waited out at home. Gallbladder problems, also associated with rapid weight loss and GLP-1 treatment, can similarly present with upper-right abdominal pain, sometimes with fever or jaundice. Any of those signs warrant prompt assessment.
If your constipation has lasted more than a week despite sensible remedies, if you notice blood in your stool, or if the bowel change accompanies significant abdominal discomfort, speak to your prescriber or GP rather than continuing to self-treat. A question our prescribers hear regularly is whether constipation is 'normal' at a specific dose, the answer is that it varies between people and often settles, but anyone struggling significantly should raise it at review rather than pushing through.
You can also explore the full side effects profile of Mounjaro for context on what is commonly reported and what the clinical guidance says about managing it.
For most people, yes. The gastrointestinal side effects of tirzepatide (constipation, nausea, indigestion) are typically most pronounced when starting treatment or stepping up to a new dose. The body adapts to the change in gut motility over days to weeks, and symptoms often settle without intervention beyond lifestyle measures. That said, some people do experience persistent constipation throughout treatment, particularly at higher doses. If it is affecting your quality of life, that is a legitimate reason to discuss timing and dose with your prescriber, it does not have to be endured silently.
Keeping protein and fibre intake consistent matters here. Mounjaro's appetite suppression means some people reduce their food intake significantly, which can reduce stool volume and worsen constipation regardless of the drug's direct effects. Eating enough, even when hunger signals are quieter, helps the gut stay active. For people specifically dealing with very loose stools rather than constipation (which can alternate with it in some cases) liquid diarrhoea on Mounjaro is covered separately. And if you want detailed, step-by-step advice on managing the symptom once it has started, how to stop constipation on Mounjaro goes further into practical relief options. Our prescribers discuss side effects including constipation as part of every consultation, start a free consultation if you would like to talk through whether Mounjaro is suitable for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.